We present the case of a 14‐year‐old boy with ulcerative colitis who was diagnosed with mesalazine‐induced interstitial nephritis ( M‐IIN ). Improvement in renal function occurred with discontinuation of mesalazine and corticosteroid therapy. We systematically searched the literature for pediatric cases of M‐IIN . There were eight cases. Majority of the cases were boys (75%) with ulcerative colitis (75%). Average duration of mesalazine use prior to the diagnosis of interstitial nephritis was 24 ± 18 months. The median dose was 1.5 g/day. M‐IIN appears to be an idiosyncratic reaction without any relation to dose or duration of mesalazine use. Although there are no guidelines to recommend routine surveillance of renal function, monitoring ...
Background: In recent years, several case reports have been published suggesting an association betw...
We report the case of a 23-year-old woman treated by mesalazine for ulcerative colitis and who subse...
Infliximab is a chimeric anti-tumor necrosis factor-alpha monoclonal antibody. Infusion related reac...
Background Acute interstitial nephritis (AIN) is an important cause of kidney injury accounting for ...
Mesalazine is the first line treatment in paediatric inflammatory bowel disease (IBD). There are sev...
5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel di...
INTRODUCTION/OBJECTIVES: Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affect...
Tubulo-interstitial nephritis (TIN) in patients affected by inflammatory bowel disease, both ulcerat...
Inflammatory bowel disease and its various treatments may affect the kidney in several ways tubuloin...
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease. Mesalizine for the first...
Background: Paediatric ulcerative colitis [UC] is more extensive than adult disease, and more often ...
We report an unusual case of Amikacin-induced nephrotoxicity in a child. The patient was a seven and...
Introduction: drugs containing 5-ASA (aminosalicylates) are widely used in the management of inflamm...
Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Recentl...
The clinical presentation and management of a young boy with acute non-oliguric renal failure associ...
Background: In recent years, several case reports have been published suggesting an association betw...
We report the case of a 23-year-old woman treated by mesalazine for ulcerative colitis and who subse...
Infliximab is a chimeric anti-tumor necrosis factor-alpha monoclonal antibody. Infusion related reac...
Background Acute interstitial nephritis (AIN) is an important cause of kidney injury accounting for ...
Mesalazine is the first line treatment in paediatric inflammatory bowel disease (IBD). There are sev...
5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel di...
INTRODUCTION/OBJECTIVES: Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affect...
Tubulo-interstitial nephritis (TIN) in patients affected by inflammatory bowel disease, both ulcerat...
Inflammatory bowel disease and its various treatments may affect the kidney in several ways tubuloin...
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease. Mesalizine for the first...
Background: Paediatric ulcerative colitis [UC] is more extensive than adult disease, and more often ...
We report an unusual case of Amikacin-induced nephrotoxicity in a child. The patient was a seven and...
Introduction: drugs containing 5-ASA (aminosalicylates) are widely used in the management of inflamm...
Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Recentl...
The clinical presentation and management of a young boy with acute non-oliguric renal failure associ...
Background: In recent years, several case reports have been published suggesting an association betw...
We report the case of a 23-year-old woman treated by mesalazine for ulcerative colitis and who subse...
Infliximab is a chimeric anti-tumor necrosis factor-alpha monoclonal antibody. Infusion related reac...